Danielle Shoots’ DEMI Fund says it provided sufficient documentation of expenditures. The city “vehemently disagrees.”
Denver seeks dismissal of VC firm’s ‘payment dispute’ on technical grounds
Startups
Welcome to Business Den’s coverage of the startup scene in Denver. Our daily coverage of business news includes coverages of the latest innovative startups in the area. Whether you’re a local entrepreneur looking to stay ahead of the curve, or simply interested in the local startup community, our coverage will keep you informed, engaged, and up to date.
Subscribe to Business Den today and stay ahead of the curve.
Head of VC firm suing Denver over tax dollars steps down
Danielle Shoots devoted the majority of her resignation letter to the topic of love. The city has yet to respond to DEMI Fund’s lawsuit.
Ibotta stock jumps on first day as a public company
Shares of IBTA closed the day at $103, 16 percent above the IPO price.
Background check company lays off 92 in LoDo
Checkr, which got a state tax incentive to expand to Denver, has an office at 1621 18th St.
VC fund suing Denver invested tax dollars in firm lacking presence in city
Danielle Shoots’ DEMI Fund sued the city last month.
The Term Sheet: Startup funding roundup for March 2024
An airport shuttle service, the parent company of Stem Ciders and a backcountry cabin rental site are among those that raised cash.
Guild founder discloses August stroke, steps down as CEO
Rachel Romer, 35, said she is relearning to walk after spending three months in the hospital.
Taxpayer returns unclear as VC firm sues city seeking funds
DEMI Fund invested in 10 firms in its first year, from a company rating media outlets based on political bias to another helping people make oil and gas investments.
Rebate app Ibotta files to go public, says it was profitable last year
The firm made $38 million in profit last year after losing $55 million the year before, per an SEC filing.
Bankrupt nutrition app $32M in debt as ex-employees sue for salaries
“We were unable to secure additional funding,” says Opsis Health CEO Kevin Grundy.
